Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies

Acta Neuropathologica

Volumn 101, Issue 6, 2001, Pages 616-624

  Broe, Melissa ^a   Shepherd, C E ^a   Milward, Elizabeth A ^a   Halliday, G M ^a  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Apoptosis; Frontal cortex; Hippocampus; Temporal cortex; TUNEL

Indexed keywords

DNA FRAGMENT; PROPIDIUM IODIDE; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN CORTEX ATROPHY; CELL COUNT; CELL DAMAGE; CELL DENSITY; CELL LABELING; CELL LOSS; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEWY BODY; MORPHOLOGY; NERVE CELL; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NICK END LABELING; NUCLEOLUS; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; ALZHEIMER DISEASE; APOPTOSIS; BASAL GANGLIA; BRAIN; CELL COUNT; DNA FRAGMENTATION; FEMALE; HUMANS; IN SITU NICK-END LABELING; LEWY BODY DISEASE; MALE; NEURONS;

EID: 0034920836     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000337     Document Type: Article

References (51)

1. DNA strand breaks in Alzheimer's disease
2. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay
3. Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL
4. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores
5. Neuropathological stageing of Alzheimer-related changes
6. Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum
7. Methods for determining numbers of cells and synapses: A case for more uniform standards of review
8. Mechanisms of neuronal death in Alzheimer's disease
9. Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer's disease
10. Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads
11. p53- and CD95-associated apoptosis in neurodegenerative diseases
12. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
13. Kainic acid-induced seizures produce necrotic, not apoptotic neurons with internucleosomal DNA cleavage: Implications for programmed cell death mechanisms
14. Neuronal and glial DNA fragmentation in Pick's disease
15. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
16. Mitochondria and apoptosis in Lewy body disorders
17. Ubiquitin-positive achromatic neurons in corticobasal degeneration
18. Simplified neuropathological diagnosis of dementia with Lewy bodies
19. Practical measures to simplify the Braak tangle stageing method for routine pathological screening
20. Is there apoptosis in Lewy body disease?
21. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
22. Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine
23. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
24. Inhibition of caspase activity induces a switch from apoptosis to necrosis
25. Dementia with Lewy bodies
26. The nomenclature of cell death: Recommendations of an ad hoc committee of the Society of Toxicologic Pathologists
27. Terminal dUTP nick end labelling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients
28. Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease
29. Antibodies to alpha-synculein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
30. DNA damage distribution in the human brain as shown by in situ end labelling: Area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology
31. Apoptosis, oncosis, and necrosis: An overview of cell death
32. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
33. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
34. Apoptosis in neurodegenerative diseases
35. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
36. Non-Alzheimer degenerative dementias
37. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition
38. Any way you cut it: A new journal policy for the use of unbiased counting methods
39. Introduction: Targeted modulation of apoptosis: A double-edged sword?
40. Evidence of apoptotic cell death in Alzheimer's disease
41. Apoptosis in Alzheimer disease: Fact or fiction
42. Alzheimer disease: DNA fragmentation indicates neuronal vulnerability, but not apoptosis
43. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death
44. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer's disease: Evidence that the disorders are distinct
45. Immunohistochemical evidence for apoptosis in Alzheimer's disease
46. Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus
47. Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia
48. In situ labelling of dying cortical neurons in normal aging and in Alzheimer's disease: Correlations with senile plaques and disease progression
49. Non-apoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
50. Cell death: The significance of apoptosis
51. Implication of cyteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates